LYRA ADENOVIRUS ASSAY— 510(k) K141931

Name: FDA 510(k) clearance K141931
Creator: U.S. Food and Drug Administration
Published: 2014-10-09

Substantially Equivalent

Quidel Corporation

FDA 510(k) clearance K141931 for LYRA ADENOVIRUS ASSAY, Substantially Equivalent on 2014-10-09. Applicant: Quidel Corporation. Device class: 2.

Clearance details

Applicant: Quidel Corporation
Product code: Code OCC
Device class: Class 2
Regulation: 21 CFR 866.3980
Advisory panel: Microbiology
Date received: 2014-07-16
Decision date: 2014-10-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Athens, OH, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code OCC

view all

K254139 — BioCode® Respiratory Pathogen Panel (RPP)2026-05-01
K242613 — NxTAG® Respiratory Pathogen Panel2024-10-02
K232775 — ID NOW Influenza A & B 22023-10-10
K231017 — Panther Fusion AdV/hMPV/RV Assay2023-05-05
K213822 — cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System2022-07-06

More clearances from Quidel Corporation

view all

Adverse events under product code OCC

product code OCC

Death: 3
Malfunction: 706
Total: 709

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.